Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/11161
Title: Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
Authors: Svobodov√°, Suzanne;Browning, Judy;MacGregor, Duncan;Pollara, Gabriele;Scolyer, Richard A;Murali, Rajmohan;Thompson, John F;Deb, Siddhartha;Azad, Arun A;Davis, Ian D;Cebon, Jonathan S
Affiliation: Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, VIC, Australia. suzanne.svobodova@ludwig.edu.au
Issue Date: 4-Nov-2010
Citation: European Journal of Cancer (oxford, England : 1990) 2010; 47(3): 460-9
Abstract: To determine the effect of Cancer-Testis Antigen (CTAg) expression on the natural history of primary cutaneous melanoma we compared its impact on prognosis with that of known prognostic factors and its relationship with other clinicopathologic characteristics. The immunohistochemical expression of three CTAgs (MAGE-A1, MAGE-A4 and NY-ESO-1) in 348 cases of stage I and stage II primary cutaneous melanoma was analysed and correlated with clinicopathologic characteristics, relapse free survival (RFS) and overall survival (OS). A Cox proportional hazards regression model was used to analyse factors which independently predicted RFS. All three CTAgs were significantly co-expressed with each other (p < 0.001). The median RFS for patients with CTAg-negative tumours and CTAg-positive tumours was 72 months and 45 months, respectively, (P = 0.008). Univariate analysis demonstrated that the impact of CTAg expression on RFS was comparable in magnitude to that of Breslow thickness, ulceration and tumour mitotic rate. Multivariate Cox regression analysis indicated that CTAg expression was a powerful independent predictor of RFS (risk ratio (RR) = 1.715, 95% confidence interval (CI) = 0.430-0.902, P = 0.010). In contrast, CTAg expression was demonstrated to have no prognostic impact on overall survival. This study demonstrates that CTAg expression in primary cutaneous melanoma is a strong independent predictor of RFS and it is comparable to other known important prognostic factors. CTAg expression has no relationship with overall survival, suggesting anti-melanoma immunity directed towards CTAg expression may contribute to the natural history of the disease. In view of these results, further investigation of the function of CTAgs and their potential use in therapeutic targeting is warranted.
Internal ID Number: 21115342
URI: http://ahro.austin.org.au/austinjspui/handle/1/11161
DOI: 10.1016/j.ejca.2010.09.042
URL: http://www.ncbi.nlm.nih.gov/pubmed/21115342
Type: Journal Article
Subjects: Adult
Aged
Antigens, Neoplasm.metabolism
Disease-Free Survival
Enzyme-Linked Immunosorbent Assay
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Male
Melanoma.metabolism.mortality.pathology
Membrane Proteins.metabolism
Middle Aged
Mitosis
Neoplasm Proteins.metabolism
Peptide Fragments.metabolism
Prognosis
Skin Neoplasms.metabolism.mortality.pathology
Skin Ulcer.mortality.pathology
Tumor Markers, Biological.metabolism
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.